Martin J. Gilligan
Corporate Officer/Principal at PHATHOM PHARMACEUTICALS, INC.
Martin J. Gilligan active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PHATHOM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2020-01-05 | - |
Career history of Martin J. Gilligan
Former positions of Martin J. Gilligan
| Companies | Position | Start | End |
|---|---|---|---|
| CELGENE | Corporate Officer/Principal | - | - |
Training of Martin J. Gilligan
| Providence College | Undergraduate Degree |
| Rutgers State University of New Jersey | Masters Business Admin |
Statistics
International
| United States | 5 |
Operational
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| PHATHOM PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Stock Market
- Insiders
- Martin J. Gilligan
- Experience
